Search Results 51-60 of 2842 for Solid

  1. Study of RP-3500 With Niraparib or Olaparib in Advanced Solid Tumors - Mayo Clinic

    ... solid tumors, determine the maximum tolerated dose (MTD) of RP-3500 in combination with Niraparib or Olaparib, examine pharmacokinetics (PK) and assess anti ...

  2. Alisertib in Treating Young Patients with Recurrent or Refractory Solid Tumors or Leukemia - Mayo Clinic

    This phase II trial is studying the side effects of and how well alisertib works in treating young patients with relapsed or refractory solid tumors or leukemia ...

  3. A Pilot Study to Evaluate the Molecular and Biological Phenotype of Peripheral Immune Cells in Solid Tumor Patients - Mayo Clinic

    A Pilot Study to Evaluate the Molecular and Biological Phenotype of Peripheral Immune Cells in Solid Tumor Patients · Overview · Participation eligibility.

  4. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

    A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors · Share · Facebook ...

  5. Cutting the Solid Skin Barrier to Expose the Mucocutaneous Separation Into the Opening of the Solid Skin Barrier - Mayo Clinic

    ... solid skin barrier (wafer) compared to a new approach of cutting the solid skin barrier to expose the mucocutaneous separation into the opening of the solid ...

  6. APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA) - Mayo Clinic

    APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors (SPARTA) · More about research at Mayo ...

  7. A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors - Mayo Clinic

    LOXO-783 may be used to treat breast cancer and other solid tumors that have a change in a particular gene (known as the PIK3CA gene). Participation could ...

  8. A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors - Mayo Clinic

    ... solid tumors including: Cohort A: Colorectal cancer (CRC);; Cohort B: Gastric and gastroesophageal junction (GEJ) cancer;; Cohort C: Triple-negative breast ...

  9. Study of Sexuality and Quality of Life in Solid Organ Transplant Recipients - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  10. MEDI5395 Advanced Solid Tumors - Mayo Clinic

    The purpose for this study is to find out if MEDI5395 and durvalumab will work and be safe for the treatment of solid tumors. Participation eligibility.